References
- Burgess AW, Cho H-S, Eigenbrot C, Ferguson KM, Garrett TPJ, Leahy DJ, Lemmon MA, Sliwkowski MX, Ward CW, Yokoyama S. An open-and-shut case? Recent insights into the activation of EGF/ErbB receptors. Mol Cell 2003; 12: 541–552
- Chang H, Riese DJ, II, Gilbert W, Stern DF, McMahan UJ. Ligands for ErbB-family receptors encoded by a neuregulin-like gene. Nature 1997; 387: 509–512
- Ferguson KM, Berger MB, Mendrola JM, Cho H-S, Leahy DJ, Lemmon MA. EGF activates its receptor by removing interactions that autoinhibit ectodomain dimeraization. Mol Cell 2003; 11: 507–517
- Feroz K, Williams E, Riese DJ, II. ErbB2 and ErbB3 do not quantitatively modulate ligand-induced ErbB4 tyrosine phosphorylation. Cell Signal 2002; 14: 793–798
- Garrett TPJ, McKern NM, Lou M, Elleman TC, Adams TE, Lovrecz GO, Zhu H-J, Walker F, Frenkel MJ, Hoyne PA, et al. Crystal structure of a truncated epidermal growth factor receptor extracellular domain bound to transforming growth factor α. Cell 2002; 110: 763–773
- Hobbs SS, Coffing SL, Le ATD, Cameron EM, Williams EE, Andrew M, Blommel EN, Hammer RP, Chang H, Riese DJ, II. Neuregulin isoforms exhibit distinct patterns of ErbB family receptor activation. Oncogene 2002; 21: 8442–8452
- Hobbs SS, Cameron EM, Hammer RP, Le ATD, Gallo RM, Blommel EN, Coffing SL, Chang H, Riese DJ, II. Five carboxyl-terminal residues of neuregulin2 are critical for stimulation of signaling by the ErbB4 receptor tyrosine kinase. Oncogene 2004; 23: 883–893
- Jones JT, Akita RW, Sliwkowski MX. Binding specificities and affinities of egf domains for ErbB receptors. FEBS Lett 1999; 447: 227–231
- Kumar R, Vadlamudi RK. The EGF family of growth factors. J Clin Ligand Assay 2000; 23: 233–237
- Normanno N, Bianco C, DeLuca A, Salomon DS. The role of EGF-related peptides in tumor growth. Frontiers Biosci 2001; 6: d685–d707
- Normanno N, Bianco C, De Luca A, Maiello MR, Salomon DS. Target-based agents against ErbB receptors and their ligands: A novel approach to cancer treatment. Endocr Relat Cancer 2003; 10: 1–21
- Ogiso H, Ishitani R, Nureki O, Fukai S, Yamanaka M, Kim J-H, Saito K, Sakamoto A, Inoue M, Shirouzu M, et al. Crystal structure of the complex of human epidermal growth factor and receptor extracellular domains. Cell 2002; 110: 775–787
- Plowman GD, Green JM, Culouscou J-M, Carlton GW, Rothwell VM, Buckley S. Heregulin induces tyrosine phosphorylation of HER4/p180erbB4. Nature 1993; 366: 473–475
- Riese DJ, II, Bermingham Y, van Raaij TM, Buckley S, Plowman GD, Stern DF. Betacellulin activates the epidermal growth factor receptor and erbB-4, and induces cellular response patterns distinct from those stimulated by epidermal growth factor or neuregulin-beta. Oncogene 1996a; 12: 345–353
- Riese DJ, II, Kim ED, Elenius K, Buckley S, Klagsbrun M, Plowman GD, Stern DF. The epidermal growth factor receptor couples transforming growth factor-a, heparin-binding epidermal growth factor-like factor, and amphiregulin to Neu, ErbB-3, and ErbB-4. J Biol Chem 1996b; 271: 20047–20052
- Riese DJ, II, van Raaij TM, Plowman GD, Andrews GC, Stern DF. The cellular response to Neuregulins is governed by complex interactions of the erbB receptor family. Mol Cell Biol 1995; 15: 5770–5776
- Riese DJ, II, Komurasaki T, Plowman GD, Stern DF. Activation of ErbB4 by the bifunctional epidermal growth factor family hormone Epiregulin is regulated by ErbB2. J Biol Chem 1998; 273: 11288–11294
- Schlessinger J. Ligand-induced, receptor-mediated dimerization and activation of EGF receptor. Cell 2002; 110: 669–672
- Strachan L, Murison JG, Prestidge RL, Sleeman MA, Watson JD, Kumble KD. Cloning and biological activity of Epigen, a novel member of the epidermal growth factor superfamily. J Biol Chem 2001; 276: 18265–18271